Reply

Càndid Villanueva^{1

2}, Isabel Graupera^{1

2}, Edilmar Alvarado¹

Affiliations

¹ Gastrointestinal Bleeding Unit Department of Gastroenterology Hospital de Sant Pau, Barcelona, Autonomous University, Barcelona, Spain.
² Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Barcelona, Spain.

Comment

Càndid Villanueva et al. Hepatology. 2017 Oct.

. 2017 Oct;66(4):1363-1364.

doi: 10.1002/hep.29397. Epub 2017 Aug 26.

Càndid Villanueva^{1

2}, Isabel Graupera^{1

2}, Edilmar Alvarado¹

¹ Gastrointestinal Bleeding Unit Department of Gastroenterology Hospital de Sant Pau, Barcelona, Autonomous University, Barcelona, Spain.
² Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Barcelona, Spain.

No abstract available

Comment on

A randomized trial to assess whether portal pressure guided therapy to prevent variceal rebleeding improves survival in cirrhosis.
Villanueva C, Graupera I, Aracil C, Alvarado E, Miñana J, Puente Á, Hernandez-Gea V, Ardevol A, Pavel O, Colomo A, Concepción M, Poca M, Torras X, Reñe JM, Guarner C. Villanueva C, et al. Hepatology. 2017 May;65(5):1693-1707. doi: 10.1002/hep.29056. Epub 2017 Mar 30. Hepatology. 2017. PMID: 28100019 Clinical Trial.
Continuation of nonselective beta-blockers for patients with liver cirrhosis and hemodynamic nonresponse?
Sauerbruch T. Sauerbruch T. Hepatology. 2017 Oct;66(4):1362-1363. doi: 10.1002/hep.29394. Epub 2017 Aug 26. Hepatology. 2017. PMID: 28734120 No abstract available.